Back to GLPGF
D. E. Shaw & Co., Inc. → GLPGF
D. E. Shaw & Co., Inc. GLPGF Position History
Lakefront Biotherapeutics NV • Healthcare
Quarters held
15
Latest value
$9.7M
Q3 2026
Peak value
$9.7M
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $6.7M |
| Q3 2022 | $5.4M |
| Q4 2022 | $2.7M |
| Q2 2023 | $673K |
| Q3 2023 | $2M |
| Q4 2023 | $3.1M |
| Q1 2024 | $1.7M |
| Q2 2024 | $416K |
| Q1 2025 | $1.6M |
| Q2 2025 | $4.3M |
| Q3 2025 | $7M |
| Q4 2025 | $9M |
| Q1 2026 | $6.5M |
| Q2 2026 | $5.9M |
| Q3 2026 | $9.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $9.7M | 325.7K | — | — |
| Q2 2026 | $5.9M | 197.8K | — | — |
| Q1 2026 | $6.5M | 215.7K | — | — |
| Q4 2025 | $9M | 275.0K | — | — |
| Q3 2025 | $7M | 201.2K | — | — |
| Q2 2025 | $4.3M | 153.2K | — | — |
| Q1 2025 | $1.6M | 63.0K | — | — |
| Q2 2024 | $416K | 16.8K | — | — |
| Q1 2024 | $1.7M | 51.7K | — | — |
| Q4 2023 | $3.1M | 75.6K | — | — |
| Q3 2023 | $2M | 57.3K | — | — |
| Q2 2023 | $673K | 16.5K | — | — |
| Q4 2022 | $2.7M | 60.0K | — | — |
| Q3 2022 | $5.4M | 126.1K | — | — |
| Q2 2022 | $6.7M | 120.7K | — | — |
Other funds holding GLPGF
$578.7M
$550.6M
$501.3M
$501.2M
$500.2M
$174.9M
$150M
$147.8M